Getinge AB 2024 AR2
The report highlights Getinge's record-breaking financial year in 2024, achieving net sales of SEK 34.8 billion. Key milestones included the acquisition of Paragonix Technologies to expand into the organ transport market and the launch of innovative products like Servo TwinView and Pulsiocare. On the sustainability front, the company reduced Scope 1 and 2 emissions from its own production by 20% compared to the previous year and increased its share of renewable energy in production to 70%. Additionally, Getinge initiated a comprehensive ESG due diligence process in its supply chain and achieved an employee engagement score of 71%.
Company: Getinge AB
Sector: Health Care
Country: Sweden
Year: 2024
Type: AR2
Pages: 186
Getinge AB
Annual Report
The report highlights Getinge's record-breaking financial year in 2024, achieving net sales of SEK 34.8 billion. Key milestones included the acquisition of Paragonix Technologies to expand into the organ transport market and the launch of innovative products like Servo TwinView and Pulsiocare. On the sustainability front, the company reduced Scope 1 and 2 emissions from its own production by 20% compared to the previous year and increased its share of renewable energy in production to 70%. Additionally, Getinge initiated a comprehensive ESG due diligence process in its supply chain and achieved an employee engagement score of 71%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees